Biogen (BIIB) PT Raised to $390 at Bernstein

February 5, 2020 3:21 PM EST
Get Alerts BIIB Hot Sheet
Price: $202.95 -2.4%

Rating Summary:
    27 Buy, 16 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 24 | New: 9
Join SI Premium – FREE

Bernstein analyst Aaron Gal raised the price target on Biogen (NASDAQ: BIIB) to $390.00 (from $370.00) while maintaining a Outperform rating.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst PT Change

Related Entities

Sanford C. Bernstein